Division of Infectious Diseases, International Center for the Advancement of Translational Science, Center for AIDS Research, University of North Carolina, School of Medicine, Chapel Hill, NC, USA.
Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC, USA.
Nat Biotechnol. 2019 Oct;37(10):1163-1173. doi: 10.1038/s41587-019-0225-9. Epub 2019 Aug 26.
A major limitation of current humanized mouse models is that they primarily enable the analysis of human-specific pathogens that infect hematopoietic cells. However, most human pathogens target other cell types, including epithelial, endothelial and mesenchymal cells. Here, we show that implantation of human lung tissue, which contains up to 40 cell types, including nonhematopoietic cells, into immunodeficient mice (lung-only mice) resulted in the development of a highly vascularized lung implant. We demonstrate that emerging and clinically relevant human pathogens such as Middle East respiratory syndrome coronavirus, Zika virus, respiratory syncytial virus and cytomegalovirus replicate in vivo in these lung implants. When incorporated into bone marrow/liver/thymus humanized mice, lung implants are repopulated with autologous human hematopoietic cells. We show robust antigen-specific humoral and T-cell responses following cytomegalovirus infection that control virus replication. Lung-only mice and bone marrow/liver/thymus-lung humanized mice substantially increase the number of human pathogens that can be studied in vivo, facilitating the in vivo testing of therapeutics.
当前,人源化小鼠模型的一个主要局限性在于,它们主要适用于分析感染造血细胞的人类特有的病原体。然而,大多数人类病原体的靶标是其他细胞类型,包括上皮细胞、内皮细胞和间充质细胞。在这里,我们展示了将包含多达 40 种细胞类型(包括非造血细胞)的人肺组织植入免疫缺陷小鼠(仅肺小鼠)中,可导致高度血管化的肺移植物的形成。我们证明了中东呼吸综合征冠状病毒、寨卡病毒、呼吸道合胞病毒和巨细胞病毒等新兴的和临床上相关的人类病原体在这些肺移植物中能够在体内复制。当将肺移植物整合到骨髓/肝/胸腺人源化小鼠中时,肺移植物会被自体人类造血细胞重新填充。我们显示,巨细胞病毒感染后会产生强烈的抗原特异性体液和 T 细胞应答,从而控制病毒复制。仅肺小鼠和骨髓/肝/胸腺-肺人源化小鼠大大增加了可在体内研究的人类病原体的数量,从而促进了治疗方法的体内测试。